bleeding on heparin - Nursing Case Study

Pathophysiology

• Primary mechanism: Heparin enhances the activity of antithrombin III, which inhibits thrombin and factor Xa, leading to decreased fibrin formation and impaired clot stability, increasing bleeding risk.

• Secondary mechanism: Heparin-induced thrombocytopenia (HIT) can paradoxically cause both thrombosis and bleeding. The formation of antibodies against platelet factor 4-heparin complexes can lead to platelet activation and consumption, reducing platelet counts and contributing to bleeding.

• Key complication: Excessive bleeding can manifest as easy bruising, hematuria, or gastrointestinal bleeding, necessitating careful monitoring of aPTT levels and platelet counts to mitigate risks.

Patient Profile

Demographics:

62-year-old female, retired school teacher

History:

• Key past medical history: Hypertension, atrial fibrillation, history of deep vein thrombosis

• Current medications: Heparin, Metoprolol, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Abnormal bleeding and bruising

• Key symptoms: Gum bleeding, increased bruising on arms and legs, mild dizziness

• Vital signs: Blood pressure 95/60 mmHg, heart rate 110 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, oxygen saturation 94% on room air

Section 1

As the clinical team conducts an initial assessment, they note that the patient's gum bleeding has increased in severity, and she now presents with petechiae scattered across her abdomen and lower extremities. Her blood pressure has dropped further to 88/56 mmHg, and her heart rate remains elevated at 112 bpm, suggesting a compensatory response to potential hypovolemia from blood loss. The nursing staff observes that her skin is cool to the touch and capillary refill is prolonged, indicating possible peripheral vasoconstriction due to decreased circulating volume. Given the patient's history of atrial fibrillation and current bradycardia on metoprolol, the elevated heart rate is concerning and warrants further investigation.

Laboratory results reveal a significant drop in hemoglobin to 9.5 g/dL from a baseline of 13 g/dL, and platelet count has decreased to 85 x 10^9/L, raising suspicion for heparin-induced thrombocytopenia (HIT). The activated partial thromboplastin time (aPTT) is elevated at 100 seconds, far exceeding the therapeutic range, confirming the anticoagulation effect of heparin is too pronounced. This combination of lab findings aligns with the clinical picture of excessive bleeding and potential HIT, prompting an immediate review of her anticoagulation regimen. The healthcare team decides to discontinue heparin and consider alternative anticoagulation strategies, potentially initiating a direct thrombin inhibitor after confirming HIT with a serotonin release assay.

The nursing team implements bleeding precautions and monitors the patient closely for signs of further hemorrhagic complications, such as gastrointestinal bleeding or intracranial hemorrhage. Fluid resuscitation is initiated with cautious administration of IV fluids to support her blood pressure while avoiding fluid overload, especially considering her underlying hypertension and heart condition. The patient's status is discussed in a multidisciplinary team meeting, emphasizing the need for vigilant monitoring and coordinated care to stabilize her condition while addressing the underlying causes of her bleeding and thrombocytopenia. This strategic approach aims to mitigate further complications and facilitate a safer transition to an appropriate anticoagulant therapy.

Section 2

As the clinical team continues to monitor the patient, they observe a change in her status. Despite discontinuation of heparin and initiation of fluid resuscitation, the patient begins to exhibit signs of further deterioration. Her blood pressure remains low at 86/54 mmHg, and her heart rate has increased to 118 bpm. Although her skin is still cool, she now appears more lethargic and confused, raising concerns about her cerebral perfusion. The patient intermittently complains of abdominal pain, and upon reassessment, her abdomen is noted to be slightly distended with increased tenderness, suggesting a potential complication such as gastrointestinal bleeding.

The nursing staff promptly reports these findings to the attending physician, who orders an urgent abdominal ultrasound and a complete blood count. The ultrasound reveals free fluid in the abdominal cavity, indicative of potential internal bleeding. Concurrently, the repeat blood tests show her hemoglobin has dropped further to 8.2 g/dL, and her platelet count has decreased to 75 x 10^9/L, exacerbating the risk of bleeding. These findings confirm the need for an urgent blood transfusion to address the ongoing blood loss and stabilize her hemodynamic status.

In response to these developments, the multidisciplinary team convenes to reassess the patient's management plan. They decide to expedite the administration of packed red blood cells and fresh frozen plasma to rapidly correct the coagulopathy and anemia. They also consider the initiation of a direct thrombin inhibitor, such as argatroban, to manage her anticoagulation needs without exacerbating her bleeding risk. The team emphasizes the importance of continued close monitoring, with a focus on neurological status, abdominal assessment, and vital sign trends, to promptly identify any further complications and adjust the treatment plan accordingly. This coordinated effort aims to stabilize the patient and prevent progression to more severe outcomes.

Section 3

As the team implements the revised management plan, they closely monitor the patient's response to the interventions. Within an hour of transfusion, the patient's vital signs begin to show modest improvement. Her blood pressure rises to 98/62 mmHg, and her heart rate decreases to 104 bpm, indicating a positive response to the blood products and fluid resuscitation. The nursing staff remains vigilant, ensuring that the transfusion is completed without any adverse reactions. They also keep a close watch on her neurological status, as her confusion and lethargy persist despite the initial stabilization of her hemodynamic parameters.

However, new concerns arise when the patient begins to exhibit signs of respiratory distress. Her respiratory rate increases to 28 breaths per minute, and she develops mild hypoxia, with her oxygen saturation dropping to 92% on room air. Upon auscultation, crackles are heard in the bilateral lung bases, suggesting potential fluid overload or transfusion-related acute lung injury (TRALI). The attending physician orders a chest X-ray, which confirms the presence of bilateral infiltrates consistent with pulmonary edema.

In light of these findings, the team adjusts the treatment plan to address this new complication. They initiate supplemental oxygen to maintain adequate oxygenation and consider the administration of diuretics to alleviate pulmonary congestion. The decision to use diuretics is carefully weighed against the risk of exacerbating the patient's hemodynamic instability. The team reiterates the importance of ongoing assessment, particularly monitoring for changes in respiratory status, renal function, and further signs of bleeding. This nuanced approach aims to balance the complex interplay of interventions required to stabilize the patient while minimizing the risk of additional complications.

Section 4

As the team continues to monitor the patient's condition, they observe a change in her status that demands immediate attention. Despite the supplemental oxygen, her oxygen saturation remains borderline, fluctuating between 91% and 93%. Her respiratory distress appears to be worsening, with an increased work of breathing and the use of accessory muscles. Her respiratory rate climbs to 32 breaths per minute, indicating that the current management plan may not be sufficient. The nursing staff notes the patient's increasing anxiety and restlessness, which could be attributed to hypoxemia or worsening pulmonary edema.

Concurrent with these observations, new diagnostic results from the laboratory arrive. The patient's latest arterial blood gas analysis reveals a respiratory alkalosis with a partial pressure of carbon dioxide (PaCO2) of 30 mmHg and a pH of 7.48. Her bicarbonate level is slightly decreased at 20 mEq/L, suggesting a compensatory response. Additionally, her complete blood count shows a significant drop in hemoglobin levels to 7.5 g/dL, indicating ongoing bleeding that may have been underestimated. Her coagulation profile demonstrates an elevated international normalized ratio (INR) of 3.5, reflecting the potent anticoagulant effect of heparin, which may be contributing to her bleeding risk.

In response to these findings, the multidisciplinary team re-evaluates their approach. The decision is made to discontinue heparin to mitigate further bleeding, and they consider administering fresh frozen plasma to address the coagulopathy. The team also discusses the possibility of transferring the patient to the intensive care unit for closer monitoring and advanced respiratory support, such as non-invasive ventilation, should her respiratory status continue to decline. This strategic adjustment underscores the critical need to balance the management of her anticoagulation therapy, respiratory distress, and hemodynamic stability as they navigate this complex clinical scenario.

Section 5

The team decides to prioritize the patient’s respiratory status while addressing the anticoagulation issue. As the patient is transferred to the intensive care unit, her vital signs are closely monitored. Her heart rate has increased to 120 beats per minute, and her blood pressure has dropped to 90/60 mmHg, indicating possible hypovolemia from ongoing bleeding. Despite the discontinuation of heparin, her INR remains elevated at 3.2, suggesting a persistent coagulopathy. The decision is made to administer fresh frozen plasma to correct the coagulopathy and support hemostasis.

In the ICU, non-invasive ventilation is initiated to improve her oxygenation and reduce her work of breathing. The patient exhibits slight improvement in oxygen saturation, which now stabilizes around 94%. However, she continues to exhibit signs of respiratory distress, with a respiratory rate of 28 breaths per minute and the use of accessory muscles. Her anxiety and restlessness decrease marginally with supplemental oxygen and reassurance. Meanwhile, a repeat complete blood count reveals a further decrease in hemoglobin to 7.0 g/dL, prompting the team to consider a blood transfusion to address the significant drop and support her hemodynamic stability.

As the team manages these interventions, they remain vigilant for any additional complications, such as potential transfusion reactions or worsening respiratory status. They discuss the need for frequent reassessments of her hemodynamic parameters and respiratory function, anticipating that continued clinical reasoning and timely adjustments will be crucial in navigating this complex case. The focus remains on achieving a stable balance between correcting her bleeding risk and supporting her compromised respiratory system.